Table 1.
General weight loss observed with GLP-1 receptor agonists based upon package inserts (kg).
| Dulaglutide [35] | Albiglutide [30] | Liraglutide [22] | Exenatide QW [26] | Exenatide BID [17] | |||
|---|---|---|---|---|---|---|---|
|
|
|
|
|||||
| 0.75 mg dose | 1.5 mg dose | 1.2 mg dose | 1.8 mg dose | 5 mg BID | 10 mg BID | ||
| (+0.2)–(−2.7) | (−0.9)–(−3.1) | (−0.4)–(−1.1) | (+0.3)–(−2.6) | (−0.2)–(−2.8) | −2.3 kg | (−1.1)–(−2.7) | (−1.6)–(−2.9) |
Weight loss ranges based upon trials in the package inserts. Background medications differed in the trials, potentially contributing to the range in weight gain/weight loss.